Literature DB >> 27260080

Role of Klotho in migration and proliferation of human dermal microvascular endothelial cells.

Margaret Markiewicz1, Kavin Panneerselvam2, Natalia Marks3.   

Abstract

PURPOSE: To examine the possible role of Klotho (Kl) in human microvasculature.
METHODS: The expression level of Kl in primary human dermal microvascular endothelial cells (HDMECs) and primary human dermal fibroblasts (HFb) was detected by real-time polymerase chain reaction amplification (qRT-PCR), Western blot analyses and immunohistochemistry. Migration of HDMECs and HFb was examined in monolayer wound healing "scratch assay" and Transwell assay. Proliferation of these cells was examined using Cell Proliferation BrdU incorporation assay.
RESULTS: Our results have shown that downregulation of Kl abrogated HDMECs migration after 48h. On the other hand, migration of HFb significantly increased after blocking Kl. Lack of Kl decreased expression of genes involved in the activation of endothelial cells and enhanced expression of genes involved in extracellular matrix remodeling and organization of connective tissue.
CONCLUSIONS: This study for the first time provides the evidence that Kl is expressed in HDMECs and HFb. Additionally, we have demonstrated that Kl is implicated in the process of angiogenesis of human dermal microvasculature. Published by Elsevier Inc.

Entities:  

Keywords:  Angiogenesis; Dermal fibroblasts; Dermal microvascular endothelial cells; Klotho

Mesh:

Substances:

Year:  2016        PMID: 27260080      PMCID: PMC4938740          DOI: 10.1016/j.mvr.2016.05.005

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  37 in total

Review 1.  Endothelial cell migration during angiogenesis.

Authors:  Laurent Lamalice; Fabrice Le Boeuf; Jacques Huot
Journal:  Circ Res       Date:  2007-03-30       Impact factor: 17.367

2.  A simple immunomagnetic protocol for the selective isolation and long-term culture of human dermal microvascular endothelial cells.

Authors:  L Richard; P Velasco; M Detmar
Journal:  Exp Cell Res       Date:  1998-04-10       Impact factor: 3.905

3.  PECAM-1 regulates proangiogenic properties of endothelial cells through modulation of cell-cell and cell-matrix interactions.

Authors:  SunYoung Park; Terri A DiMaio; Elizabeth A Scheef; Christine M Sorenson; Nader Sheibani
Journal:  Am J Physiol Cell Physiol       Date:  2010-09-01       Impact factor: 4.249

4.  Klotho is associated with VEGF receptor-2 and the transient receptor potential canonical-1 Ca2+ channel to maintain endothelial integrity.

Authors:  Tetsuro Kusaba; Mitsuhiko Okigaki; Akihiro Matui; Manabu Murakami; Kazuhiko Ishikawa; Taikou Kimura; Kazuhiro Sonomura; Yasushi Adachi; Masabumi Shibuya; Takeshi Shirayama; Shuji Tanda; Tsuguru Hatta; Susumu Sasaki; Yasukiyo Mori; Hiroaki Matsubara
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-21       Impact factor: 11.205

Review 5.  Regulation and function of the FGF23/klotho endocrine pathways.

Authors:  Aline Martin; Valentin David; L Darryl Quarles
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

6.  Klotho suppresses renal tubulo-interstitial fibrosis by controlling basic fibroblast growth factor-2 signalling.

Authors:  Xu Guan; Ling Nie; Ting He; Ke Yang; Tangli Xiao; Song Wang; Yunjian Huang; Jingbo Zhang; Junping Wang; Kumar Sharma; Youhua Liu; Jinghong Zhao
Journal:  J Pathol       Date:  2014-09-30       Impact factor: 7.996

7.  Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility.

Authors:  Tura C Camilli; Mai Xu; Michael P O'Connell; Bonnie Chien; Brittany P Frank; Sarah Subaran; Fred E Indig; Patrice J Morin; Stephen M Hewitt; Ashani T Weeraratna
Journal:  Pigment Cell Melanoma Res       Date:  2010-12-01       Impact factor: 4.693

8.  Development and characterization of monoclonal antibodies to detect klotho.

Authors:  Astha Maltare; Angela K Nietz; Ann M Laszczyk; Taylor S Dunn; Mary E Ballestas; Mary Ann Accavitti-Loper; Gwendalyn D King
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2014-12

Review 9.  Matrix metalloproteinases, angiogenesis, and cancer: commentary re: A. C. Lockhart et al., Reduction of wound angiogenesis in patients treated with BMS-275291, a broad spectrum matrix metalloproteinase inhibitor. Clin. Cancer Res., 9: 00-00, 2003.

Authors:  Joyce E Rundhaug
Journal:  Clin Cancer Res       Date:  2003-02       Impact factor: 12.531

Review 10.  Controlling the angiogenic switch: a balance between two distinct TGF-b receptor signaling pathways.

Authors:  Marie-Jose Goumans; Franck Lebrin; Gudrun Valdimarsdottir
Journal:  Trends Cardiovasc Med       Date:  2003-10       Impact factor: 6.677

View more
  4 in total

1.  βklotho is essential for the anti-endothelial mesenchymal transition effects of N-acetyl-seryl-aspartyl-lysyl-proline.

Authors:  Rongfen Gao; Keizo Kanasaki; Jinpeng Li; Munehiro Kitada; Toshiro Okazaki; Daisuke Koya
Journal:  FEBS Open Bio       Date:  2019-04-22       Impact factor: 2.693

Review 2.  N-acetyl-seryl-aspartyl-lysyl-proline is a valuable endogenous antifibrotic peptide for kidney fibrosis in diabetes: An update and translational aspects.

Authors:  Keizo Kanasaki
Journal:  J Diabetes Investig       Date:  2020-03-11       Impact factor: 4.232

3.  Patients with Earlobe Crease May Associate with Lower Concentration of the Age-Suppressing Hormone Klotho.

Authors:  Jian Wang; Zhan-Fang Zhu; Fu-Qiang Liu; Cun Liu; Ai-Mei Ou-Yang; Wei-Wei Chen; En-Guo Wang; Xi-Ming Wang
Journal:  Int J Gen Med       Date:  2021-11-25

Review 4.  Changes in expression of klotho affect physiological processes, diseases, and cancer.

Authors:  Nguyen Thi Xuan; Nong Van Hai
Journal:  Iran J Basic Med Sci       Date:  2018-01       Impact factor: 2.699

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.